Rapid infectious disease test Xpert® HPV

for sexually transmitted diseasesDNA extractionHPV

Human papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide. On a global basis, HPV genotypes 16 and 18 are associated with approximately 71% of all cases of cervical cancer, and HPV genotype 45 is associated with approximately 6% of additional cases of cervical cancer.1 Cervical cancer screening programs vary, based upon local guidance that consider testing algorithms, resources, skill set and infrastructure. Most HPV NAAT tests are complicated to use and batch testing can delay results critical for scheduling patient consultations for follow-up testing or colposcopy. The ideal HPV test can flexibly integrate easily into most settings, and enable physicians to effectively risk stratify patients based on cytology and high-risk HPV. Further, rapid comprehensive HPV results that include integrated high-risk HPV 16 and HPV 18 testing strategies support quality decision making for colposcopy referral.2 The Solution Now both cytology and molecular laboratories can run a HPV test with confidence. Based on the GeneXpert® technology, Xpert HPV automates the test process including DNA extraction, amplification, and detection in one fully integrated cartridge. On-demand HPV testing — a next generation solution: Highest risk HPV 16 and HPV 18/45 call-outs enhances patient management Optimized detection of 14 hrHPV reported as: HPV16, HPV18/45 or other hrHPV (31, 33, 35, 52, 58; 51, 59; 39, 56, 66, 68) E6/E7 oncogenes target eliminates concerns in case of L1 gene deletion3 Sample adequacy control (SAC) confirms patient sample contains human DNA